Citi analyst Brendan Digan assumes coverage on Guardant Health (NASDAQ: GH) with a Buy rating and a price target of $215.00.

For an analyst ratings summary and ratings history on Guardant Health click here. For more ratings news on Guardant Health click here.

Shares of Guardant Health closed at $144.07 yesterday.